top of page
Log In
Home
How NDR is Fighting ALS
Information on ALS
Research Benefiting Patients
Donate
Groups
Members
For Patients
Current Treatments
Clinical Trials in the US
TVALA Clinical Trial
For Researchers
Current Projects
2019-2022 Funded Researchers
Biorepositories
Reagents Available
White Papers
Video Sessions
News
About
Contact
Privacy Policy
More
Use tab to navigate through the menu items.
Projects Funded
by NDR
2021-2024 Term
David Borchelt
Testing ALS drug synergy in ALS mouse models
Learn More About David Borchelt
Matt Farrer &
Rejko Krueger
CRISPR modified mouse targeting ALS associated metabolic pathways
Learn More About Matt Farrer
Learn More About Rejko Krueger
Susanne
Petri
Investigating the therapeutic potential of drug interventions on the microglia in ALS mouse models
Learn More About Susanne Petri
Peng Jin
Epigenetics in ALS patients
Learn More About Peng Jin
Lauren Kokai
Drug efficacy in ALS cell dysfunctional assay; Develop dynamic therapeutic systems
Learn More About Lauren Kokai
Sayuri Miyamoto
Lipidomics and lipid marker discovery from ALS tissues
Learn More About Sayuri Miyamoto
Gerardo Morfini
Axon transport and phosphokinase signaling in ALS models
Learn More About Gerardo Morfini
Steven Pelech
Phosphosite antibody reagent development for ALS biomarker discovery
Learn More About Steven Pelech
Learn More About Kinexus
Chris Shaw
Biomarker detection in mice and humans
Learn More About Chris Shaw
Teepu Siddique
Regulating protein processing and drug development; ALS commons
Learn More About Teepu Siddique
Chandler Walker
Restore muscle mass in ALS patients; ASC-CM for ALS therapy
Learn More About Chandler Walker
Jessica Morrice
Drugs efficacy in normal cell functional assays, cytokine responses
Learn More About Jessica Morrice
Robert Naviaux & Robert Pascuzzi
Metabolomics study in ALS patients
Learn More About Robert Naviaux
Learn More About Robert Pascuzzi
bottom of page
